Search filters

List of works by Remco A. Koster

A volumetric absorptive microsampling LC-MS/MS method for five immunosuppressants and their hematocrit effects

scientific article published on 20 March 2019

Analysis of remifentanil with liquid chromatography-tandem mass spectrometry and an extensive stability investigation in EDTA whole blood and acidified EDTA plasma

scientific article

Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method

scientific article published in February 2014

Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients

scientific article published in December 2016

Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume

scientific article published on 16 March 2011

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.

scientific article published on 24 October 2017

Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis

scientific article published on 27 December 2014

Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.

scientific article published on 16 March 2017

Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery

scientific article published on 19 April 2013

Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse.

scientific article published in April 2014

Have we got 'patient-centric sampling' right?

scientific article published on 10 July 2020

Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method

scientific article published on 01 August 2014

Reply to Verhaeghe et al.

scientific article

Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.

scientific article

Simple and robust LC-MS/MS analysis method for therapeutic drug monitoring of micafungin

scientific article published on 04 June 2018

Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS.

scientific article

Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.

scientific article published on 25 April 2016

The performance of five different dried blood spot cards for the analysis of six immunosuppressants

scientific article published on 01 January 2015

The relation of the number of hydrogen-bond acceptors with recoveries of immunosuppressants in DBS analysis

scientific article published on 01 January 2015

Therapeutic drug monitoring by dried blood spot: progress to date and future directions

scientific article published on 01 November 2014

Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma

scientific article published on 10 January 2013

UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasma

scientific article published on 22 July 2020

Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment

scientific article published on 30 September 2019

What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?

scientific article published in January 2015

Paulina is supported by:

About Paulina

Help